These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 21933944)

  • 1. Immunity and bacterial colonisation in bronchiectasis.
    Whitters D; Stockley R
    Thorax; 2012 Nov; 67(11):1006-13. PubMed ID: 21933944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lower airway microbiology and cellularity in children with newly diagnosed non-CF bronchiectasis.
    Kapur N; Grimwood K; Masters IB; Morris PS; Chang AB
    Pediatr Pulmonol; 2012 Mar; 47(3):300-7. PubMed ID: 21901858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TAP deficiency is also a cause of bronchiectasis.
    Zimmer J; Sleiman M; Poli A; Michel T; Hentges F
    Thorax; 2013 May; 68(5):490-1. PubMed ID: 23299963
    [No Abstract]   [Full Text] [Related]  

  • 4. Authors' response to 'TAP deficiency is also a cause of bronchiectasis'.
    Whitters D; Stockley RA
    Thorax; 2013 May; 68(5):491. PubMed ID: 23717829
    [No Abstract]   [Full Text] [Related]  

  • 5. Update on non-cystic fibrosis bronchiectasis.
    Bilton D
    Curr Opin Pulm Med; 2008 Nov; 14(6):595-9. PubMed ID: 18812838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Airway microbiology and host defences in paediatric non-CF bronchiectasis.
    Grimwood K
    Paediatr Respir Rev; 2011 Jun; 12(2):111-8. PubMed ID: 21458739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical measures of disease in adult non-CF bronchiectasis correlate with airway microbiota composition.
    Rogers GB; van der Gast CJ; Cuthbertson L; Thomson SK; Bruce KD; Martin ML; Serisier DJ
    Thorax; 2013 Aug; 68(8):731-7. PubMed ID: 23564400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacterial colonisation in patients with bronchiectasis: microbiological pattern and risk factors.
    Angrill J; Agustí C; de Celis R; Rañó A; Gonzalez J; Solé T; Xaubet A; Rodriguez-Roisin R; Torres A
    Thorax; 2002 Jan; 57(1):15-9. PubMed ID: 11809984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction between Pseudomonas aeruginosa and host defenses in cystic fibrosis.
    Marshall BC; Carroll KC
    Semin Respir Infect; 1991 Mar; 6(1):11-8. PubMed ID: 1909452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toll-like receptors in the host defense against Pseudomonas aeruginosa respiratory infection and cystic fibrosis.
    McIsaac SM; Stadnyk AW; Lin TJ
    J Leukoc Biol; 2012 Nov; 92(5):977-85. PubMed ID: 22892106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pseudomonas aeruginosa, cyanide accumulation and lung function in CF and non-CF bronchiectasis patients.
    Ryall B; Davies JC; Wilson R; Shoemark A; Williams HD
    Eur Respir J; 2008 Sep; 32(3):740-7. PubMed ID: 18480102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Value of serology in predicting Pseudomonas aeruginosa infection in young children with cystic fibrosis.
    Douglas TA; Brennan S; Berry L; Winfield K; Wainwright CE; Grimwood K; Stick SM; Sly PD;
    Thorax; 2010 Nov; 65(11):985-90. PubMed ID: 20889526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controlled trial of cycled antibiotic prophylaxis to prevent initial Pseudomonas aeruginosa infection in children with cystic fibrosis.
    Tramper-Stranders GA; Wolfs TF; van Haren Noman S; van Aalderen WM; Nagelkerke AF; Nuijsink M; Kimpen JL; van der Ent CK
    Thorax; 2010 Oct; 65(10):915-20. PubMed ID: 20729233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-neutrophil cytoplasmic antibodies (ANCA) in serum and bronchoalveolar lavage fluids of cystic fibrosis patients and patients with idiopathic bronchiectasis.
    Cobanoğlu N; Ozcelik U; Cetin I; Yalçin E; Doğru D; Kiper N; Bakkaloğlu A
    Turk J Pediatr; 2010; 52(4):343-7. PubMed ID: 21043377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pseudomonas aeruginosa infection in cystic fibrosis. Relationship between mucoid strains of Pseudomonas aeruginosa and the humoral immune response.
    Hoiby N
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1974 Aug; 82(4):551-8. PubMed ID: 4213330
    [No Abstract]   [Full Text] [Related]  

  • 16. Non-cystic fibrosis bronchiectasis: diagnosis and management in 21st century.
    Goeminne P; Dupont L
    Postgrad Med J; 2010 Aug; 86(1018):493-501. PubMed ID: 20709772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chronic bronchial infection: the problem of Pseudomonas aeruginosa].
    Cantón R; Fernández Olmos A; de la Pedrosa EG; del Campo R; Antonia Meseguer M
    Arch Bronconeumol; 2011 Jun; 47 Suppl 6():8-13. PubMed ID: 21703473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PPARγ is reduced in the airways of non-CF bronchiectasis subjects and is inversely correlated with the presence of Pseudomonas aeruginosa.
    Burr LD; Rogers GB; Chen AC; Taylor SL; Bowler SD; Keating RL; Martin ML; Hasnain SZ; McGuckin MA
    PLoS One; 2018; 13(8):e0202296. PubMed ID: 30114278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacterial colonisation of lower airways in health and chronic lung disease.
    Weinreich UM; Korsgaard J
    Clin Respir J; 2008 Apr; 2(2):116-22. PubMed ID: 20298316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positive immediate skin tests in cystic fibrosis: a possible role for Pseudomonas infection.
    Clarke CW; Hampshire P; Hannant C
    Br J Dis Chest; 1981 Jan; 75(1):15-21. PubMed ID: 6789859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.